NEW YORK (GenomeWeb) – The US Food and Drug Administration said on Tuesday that it has granted the first CLIA waiver to a nucleic acid-based flu diagnostic test, the Alere i Influenza A&B, allowing it to be used in a wider variety of healthcare settings.

Alere's test had previously been available for use only in certain laboratories. With the CLIA waiver, it can be distributed to non-traditional laboratory sites, including doctors' offices, emergency rooms, health department clinics, and other healthcare facilities, the FDA said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.